Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 3;24(1):240.
doi: 10.1186/s12866-024-03381-7.

CRISPR-Cas3 and type I restriction-modification team up against blaKPC-IncF plasmid transfer in Klebsiella pneumoniae

Affiliations

CRISPR-Cas3 and type I restriction-modification team up against blaKPC-IncF plasmid transfer in Klebsiella pneumoniae

Yang Yang et al. BMC Microbiol. .

Abstract

Objective: We explored whether the Clustered regularly interspaced short palindromic repeat (CRISPR)-Cas and restriction-modification (R-M) systems are compatible and act together to resist plasmid attacks.

Methods: 932 global whole-genome sequences from GenBank, and 459 K. pneumoniae isolates from six provinces of China, were collected to investigate the co-distribution of CRISPR-Cas, R-M systems, and blaKPC plasmid. Conjugation and transformation assays were applied to explore the anti-plasmid function of CRISPR and R-M systems.

Results: We found a significant inverse correlation between the presence of CRISPR and R-M systems and blaKPC plasmids in K. pneumoniae, especially when both systems cohabited in one host. The multiple matched recognition sequences of both systems in blaKPC-IncF plasmids (97%) revealed that they were good targets for both systems. Furthermore, the results of conjugation assay demonstrated that CRISPR-Cas and R-M systems in K. pneumoniae could effectively hinder blaKPC plasmid invasion. Notably, CRISPR-Cas and R-M worked together to confer a 4-log reduction in the acquisition of blaKPC plasmid in conjugative events, exhibiting robust synergistic anti-plasmid immunity.

Conclusions: Our results indicate the synergistic role of CRISPR and R-M in regulating horizontal gene transfer in K. pneumoniae and rationalize the development of antimicrobial strategies that capitalize on the immunocompromised status of KPC-KP.

Keywords: Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella Pneumoniae; bla KPC harbouring plasmids; CRISPR-Cas system; Horizontal gene transfer; Type I R-M systems.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Distribution of CRISPR-Cas systems, R-M systems, and blaKPC in 932 completely sequenced global Klebsiella pneumoniae(A) Presence of CRISPR-Cas systems, R-M systems, and blaKPC in 271 blaKPC harbouring isolates in (i), 247 CRISPR-positive isolates, and 360 R-M positive isolates. (B) Distribution of different types of CRISPR-Cas and R-M systems in Klebsiella pneumoniae co-harbouring CRISPR, R-M and blaKPC
Fig. 2
Fig. 2
Characteristics of blaKPC harbouring plasmids extracted from 932 global Klebsiella pneumoniae. (A) The incompatibility type distribution of blaKPC harbouring plasmids. (B) The number of proto-spacers (i) and R-M recognition sites among IncF blaKPC harbouring plasmids (ii)
Fig. 3
Fig. 3
Conjugation frequencies of p187-2 plasmid in strains with or without type I R-M systems. (A) Comparative analysis of IncF blaKPC harbouring plasmids using p187-2 as the reference. The CRISPR and R-M targeted regions are illustrated with red dotted boxes. The detailed information on these plasmids is listed in the dataset. (B) Type I R-M systems influence the conjugation of the p187-2 plasmid. The data represent the mean ± SD for three independent biological replicates. ****p < 0.0001 indicate significant differences between strains and the control group as determined using one-way ANOVA with Dunnett correction
Fig. 4
Fig. 4
Conjugation frequencies of p187-2 in strains with or without CRISPR-Cas or type I R-M systems. The data represent the mean ± SD for three independent biological replicates. ****p < 0.0001 indicates significant differences between strains harbouring CRISPR or R-M systems and the control group as determined using one-way ANOVA with Dunnett correction. “ns” indicates no significant differences between strains harbouring CRISPR and strains harbouring R-M
Fig. 5
Fig. 5
CRISPR-Cas and R-M provide additive defense against pl87-2 plasmid. (A) Schematic representation of donor and recipient strains used to assess the individual and collective contributions of R-M and CRISPR-Cas to genome defense. (B) Conjugation frequencies of p187-2 in different derivatives strains. Results of these experiments show that the combined effects of CRISPR-Cas and R-M outweigh the effect of either system alone. Data represent results of a minimum of three independent conjugations for all experiments shown. The open circle indicates that no valid conjugant was obtained (JS700, CRISPR&ID R-M). ****p < 0.0001 indicate significant differences between strains and corresponding CRISPR & R-M group as determined using one-way ANOVA with Dunnett correction. E.g., the type IA R-M strains were compared with type IA R-M & CRISPR strains; the CRISPR strains were compared with type IA R-M & CRISPR, type IB R-M & CRISPR, and type ID R-M & CRISPR strains

References

    1. Chen L, Mathema B, Chavda KD, DeLeo FR, Bonomo RA, Kreiswirth BN. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. TRENDS MICROBIOL. 2014;22(12):686–96. doi: 10.1016/j.tim.2014.09.003. - DOI - PMC - PubMed
    1. Fu P, Tang Y, Li G, Yu L, Wang Y, Jiang X. Pandemic spread of bla((KPC-2)) among Klebsiella pneumoniae ST11 in China is associated with horizontal transfer mediated by IncFII-like plasmids. INT J ANTIMICROB AG. 2019;54(2):117–24. doi: 10.1016/j.ijantimicag.2019.03.014. - DOI - PubMed
    1. Tang Y, Fu P, Zhou Y, Xie Y, Jin J, Wang B, Yu L, Huang Y, Li G, Li M, et al. Absence of the type I-E CRISPR-Cas system in Klebsiella pneumoniae clonal complex 258 is associated with dissemination of IncF epidemic resistance plasmids in this clonal complex. J ANTIMICROB CHEMOTH. 2020;75(4):890–5. doi: 10.1093/jac/dkz538. - DOI - PubMed
    1. Zhou Y, Tang Y, Fu P, Tian D, Yu L, Huang Y, Li G, Li M, Wang Y, Yang Z, et al. The type I-E CRISPR-Cas system influences the acquisition of Bla KPC-IncF plasmid in Klebsiella pneumonia. EMERG MICROBES INFEC. 2020;9(1):1011–22. doi: 10.1080/22221751.2020.1763209. - DOI - PMC - PubMed
    1. Zhou Y, Tian D, Tang Y, Yu L, Huang Y, Li G, Li M, Wang Y, Yang Z, Poirel L, et al. High-risk KPC-producing Klebsiella pneumoniae lack type I R-M systems. INT J ANTIMICROB AG. 2020;56(2):106050. doi: 10.1016/j.ijantimicag.2020.106050. - DOI - PubMed

Substances